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Cdc42-induced actin filaments are protected from capping
protein
Minzhou Huang*, Changsong Yang*, Dorothy A. Schafer†, John A. Cooper†,
Henry N. Higgs‡ and Sally H. Zigmond*
Each actin filament has a pointed and a barbed end,
however, filament elongation occurs primarily at the
barbed end. Capping proteins, by binding to the barbed
end, can terminate this elongation. The rate of capping
depends on the concentration of capping protein [1],
and thus, if capping terminates elongation, the length
of filaments should vary inversely with the
concentration of capping protein. In cell extracts, such
as those derived from neutrophils, new actin filaments
can be nucleated by addition of GTPγS-activated Cdc42
(a small GTPase of the Rho family). To determine
whether elongation of these filaments is terminated by
capping, we manipulated the concentration of capping
protein, the major calcium-independent capping protein
in neutrophils, and observed the effects on filament
lengths. Depletion of 70% of the capping protein from
extracts increased the mean length of filaments
elongated from spectrin–actin seeds (very short actin
filaments with free barbed ends) but did not increase
the mean length of filaments induced by Cdc42.
Furthermore, doubling the concentration of capping
protein in cell extracts by adding pure capping protein
did not decrease the mean length of filaments induced
by Cdc42. These results suggest that the barbed ends of
Cdc42-induced filaments are protected from capping by
capping protein.
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Results and discussion
Neutrophil cytoplasm contains a high concentration
(~2 µM) of capping protein, the non-muscle form of capZ.
This concentration greatly exceeds that required to cap a
barbed end (Kd ~1 nM). Thus, at steady state, essentially
all of the barbed ends should be capped. Furthermore, the
on-rate of capping is sufficiently fast (106/M/second) that
the half-time of capping a free barbed end in vivo is pre-
dicted to be about 0.6 seconds [2]. By limiting the duration
of elongation, capping could limit a filament’s length. As
the rate of capping depends on the concentration of
capping protein [1,2], and if capping terminates elongation,
the length of filaments should vary inversely with the con-
centration of capping protein. Incubation of GTPγS-
charged Cdc42 (referred to as Cdc42) with neutrophil high
speed supernatant (HSS) induces the formation of actin fil-
aments [3,4]. The number of filaments increases over time;
after 5 minutes, about 10 nM filaments are present. The
mean length of filaments changes little between 15 seconds
and 5 minutes. Thus, as each filament is formed, it appears
to elongate only briefly. We were interested in determining
whether elongation was terminated by capping.
Depletion of capping protein from HSS did not increase the
length of actin filaments induced by Cdc42
To investigate whether the rate of capping determines the
length of filaments induced by Cdc42 in cell extracts, the
concentration of capping protein was decreased by immun-
odepletion. Using polyclonal antibodies, we depleted
69 ± 7% (n = 6) of the capping protein from HSS (Figure 1a).
This depletion increased the length of filaments elongated
from spectrin–actin seeds. In the experiment shown in
Figure 1b,c, the length increased from 0.48 µm (n = 57) in
mock-depleted HSS to 0.96 µm (n = 120) in capping-
protein-depleted HSS (p = 0.005 by χ2 test).
Depletion of capping protein did not, however, increase
the mean length of filaments induced in HSS by Cdc42:
the mean length was 1.76 µm (n = 94) in mock-depleted
HSS and 1.56 µm (n = 114) in capping-protein-depleted
HSS (Figure 1d,e). In six separate depletion experiments,
using two different antibodies, and varying the duration of
incubation between 15 sec and 5 min, capping-protein
depletion always increased the mean length of filaments
elongated from spectrin–actin seeds but never increased
the mean length of Cdc42-induced filaments. 
Addition of exogenous capping protein to HSS did not
decrease the length of filaments induced by Cdc42
We next investigated whether increasing capping protein
concentration would decrease filament length. To deter-
mine the amount of capping protein required to double
the concentration in the HSS, we first titrated the capping
activity of both HSS and purified capping protein (from
chicken brain [1]) with spectrin–actin seeds (Figure 2a).
Doubling the concentration of capping protein in HSS
(~170 nM) did not decrease the lengths of filaments
induced by Cdc42 (Figure 2b–d). Even increasing the
concentration by approximately threefold to 500 nM did
not result in shorter filaments (data not shown). In seven
experiments, addition of capping protein (60–500 nM) did
not decrease the mean length of Cdc42-induced filaments. 
To determine whether an effect of capping protein could
be detected when the filaments were as long as those
induced by Cdc42, filaments were nucleated in pure actin
from spectrin–actin seeds and allowed to elongate for
1 minute with varying concentrations of capping protein.
In the absence of capping protein, the mean filament
length after incubation in 1.5 µM actin was 0.8 µm, and in
3 µM actin was 1.75 µm. At both actin concentrations,
inclusion of capping protein decreased mean filament
length, with 80 nM capping protein causing an approxi-
mately 50% decrease (Figure 2e). The rates of both fila-
ment elongation and capping were slower when assayed
by electron microscopy than by pyrenylactin polymeriza-
tion presumably because, with the small amount of
protein present (10 µl, less than 0.2 mg/ml protein),
adsorption to the electron microscopy grid surface
decreased protein concentrations. In studies with cell
supernatants, where the protein concentration was
4 mg/ml, the effects of adsorption would be less.
To determine whether purified capping protein was
active in HSS, we examined its effect on filaments grown
from spectrin–actin seeds. The length of filaments
induced by spectrin–actin seeds in control HSS was near
the lower limit of detection. After capping-protein deple-
tion, however, the filaments were longer and allowed us
to determine whether the addition of purified capping
protein would decrease filament length. Addition of
60 nM capping protein to the depleted supernatant
decreased the mean length from 0.96 µm (n = 120) to
0.51 µm (n = 77). Comparable decreases were found in
two additional experiments. Thus, purified capping
protein did limit elongation of spectrin–actin-induced fila-
ments in HSS. 
What protects Cdc42-induced filaments from capping?
The lack of effect of capping protein concentration on the
length of Cdc42-induced filaments suggests that the
barbed ends of these filaments are protected from capping.
As Cdc42 is thought to nucleate new filaments through the
Arp2/3 complex [5–7], we investigated whether filaments
nucleated in pure actin by Arp2/3 activated by a carboxy-
terminal fragment of N-WASP — a member of the
Wiskott–Aldrich syndrome protein (WASP) family — were
protected from capping. The carboxy-terminal fragment
(called VCA) was expressed as a fusion protein with glu-
tathione-S-transferase (GST–VCA). We first examined the
rate of capping of Arp2/3-nucleated filaments following
dilution into pyrenylactin with various concentrations of
capping protein. Capping of Arp2/3-nucleated filaments
was similar to that of filaments elongating from
spectrin–actin seeds (see Supplementary material).
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Figure 1
Immunodepletion of capping protein. (a) Depletion was achieved by
incubating HSS with affinity-purified rabbit polyclonal antibodies bound
to protein A beads. The antibodies were directed against the carboxy-
terminal 27 amino acids of the β2 subunit of chicken non-muscle
capping protein (CP) [12]. For mock depletion, protein A beads were
treated with 0.1% BSA or pre-immune immunoglobulin. Lane 1, mock-
depleted supernatant (25 µg protein); lane 2, CP-depleted supernatant
(25 µg protein); lanes 3–7, control supernatant (25, 12.5, 6.3, 3.2 and
1.6 µg protein, respectively). The blot was also probed with an anti-
actin antibody as a loading control (lower panel). (b,c) Length
distribution of filaments induced by spectrin–actin seeds. Seeds
(prepared according the method of Lin and colleagues [13]) were
incubated at 1.5 nM (determined from the initial rate of pyrenylactin
polymerization) for 1 min in (b) mock-depleted supernatant or (c) CP-
depleted supernatant (80% depletion) before negative staining.
Electron micrographs were taken and analyzed as described previously
[4]. The lengths of all filaments longer than 0.25 µm were measured
from photographs. The vertical axis is the number of filaments with a
length equal to the value on the horizontal axis ± 0.25 µm. For
comparison, the total filament number was normalized to 100; actual
filament counts were 57 and 120 for (b,c), respectively. (d,e) Length
distribution of filaments induced by Cdc42. Recombinant Cdc42
(1 µM; expressed in a baculovirus insect cell expression system [3])
was incubated for 1 min in (d) mock-depleted or (e) CP-depleted
supernatant as in (b,c). The number of filaments in each sample was
normalized to 100; the actual number of filaments counted was 94 and
114 in (d,e), respectively.
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As capping was assayed on pre-formed filaments, we
would not detect an inhibition that was present only tran-
siently after nucleation. To determine whether newly
nucleated Arp2/3 filaments were protected, we examined
the ability of capping protein to cap barbed ends soon
after nucleation by including capping protein with
GST–VCA, Arp2/3 and actin during the nucleation reac-
tion. In the absence of capping protein, nucleation sites
increased rapidly between 1 and 2 minutes (Figure 3).
The presence of capping protein decreased free barbed
ends present at 2 minutes. Thus, barbed ends of Arp2/3-
nucleated filaments could be capped within 1 minute of
their formation. The extent of capping at 2 and 5 minutes
was similar and comparable to that of spectrin–actin seeds
(Figure 3). Thus, the inhibition of capping does not
appear to be a structural feature of an Arp2/3-nucleated fil-
ament. Rather, protection seems to depend on a factor
present in the supernatant.
The  increased length of Cdc42-induced filaments com-
pared to that of spectrin–actin seed-induced filaments
could result from their elongating at a faster rate or for a
longer duration [4]. Our study suggests that filaments
induced in HSS by Cdc42 are protected from capping by
an inhibitor of capping (designated I in the model in
Figure 4). As spectrin–actin seeds are not protected, the
inhibitor must recognize some component at the barbed
end of Cdc42-induced filaments. The nature of the
inhibitor remains to be defined. Inhibition of capping
might, by allowing prolonged elongation, account for the
increased length of Cdc42-induced filaments as compared
with those induced by spectrin–actin seeds. Nevertheless,
because even at very early times (15 seconds), Cdc42-
induced filaments are significantly longer than those
induced by spectrin–actin seeds, they may also elongate
more rapidly (see discussion in [4]).
In various cell extracts, Cdc42 activates a member of the
WASP family, which in turn stimulates the Arp2/3
complex to nucleate a filament with a free barbed end
[6–11]. As the molecular nature of the proteins involved in
neutrophil HSS has not yet been defined, we have used
generic names in the model shown in Figure 4. We
propose that Cdc42 activates nucleation and promotes
elongation of the induced filaments. Promotion of elonga-
tion includes protecting the induced barbed ends from
capping by capping protein. As elongation does not appear
to be limited by capping protein concentration, we
propose that it is terminated by dissociation of the elonga-
tion-promoting complex.
Brief Communication 981
Figure 2
Increasing the concentration of capping
protein. (a) To titrate purified capping protein
and cell extracts, spectrin–actin seeds
(80 nM) were incubated in 10 µl for 2 min with
buffer alone, or with serial twofold dilutions of
capping protein (CP, blue triangles) starting
with 300 nM (4 on the horizontal axis), or
serial twofold dilutions of HSS (red circles)
starting with 0.66 mg/ml protein (4 on the
horizontal axis). After incubation, the solutions
were diluted into 1 ml 1.5 µM pyrenylactin,
and free ends determined from the rate of
polymerization. (b–d) Effect of adding
capping protein on the length of Cdc42-
induced filaments. Supernatants incubated
with 1 µM Cdc42 with addition of (b) 0 nM,
(c) 160 nM or (d) 330 nM capping protein for
1 min produced filaments with mean lengths
of 1.33 µm (n = 122), 1.36 µm (n = 112) and
1.51 µm (n = 98), respectively. (e) Filament
length as a function of capping protein
concentration. Filaments nucleated from
spectrin–actin seeds in 1.5 µm (red) or 3 µM
(blue) actin with varying concentrations of
capping protein were incubated at room
temperature on the electron microscope grid
for 1 min before washing and staining.
Filaments were measured on photographs.
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Supplementary material
Additional methodological detail and a figure comparing the time course
of capping of Arp2/3-nucleated filaments and filaments induced by spec-
trin–actin seeds are available at http://current-biology.com/supmat/sup-
matin.htm.
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Figure 3
Capping protein can cap Arp2/3-nucleated filaments soon after their
nucleation. The time course of barbed-end nucleation sites induced by
200 nM GST–VCA, 50 nM Arp2/3 and 2 µM muscle actin was
determined in the absence (red circles) and presence (red triangles) of
80 nM capping protein. Free barbed ends were determined after
dilution by measuring the rate of polymerization of 1.5 µM pyrenylactin.
Capping protein had similar ability to cap filaments during the peak of
nucleation and 3 min after nucleation was complete. The
polymerization induced by spectrin–actin seeds that had been
incubated for 2 min in the absence (blue circle) or presence (blue
triangle) of 80 nM capping protein is also shown. See Supplementary
material for additional methodological detail on the preparation of
GST–VCA and Arp2/3. 
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Figure 4
Model of the mechanism of Cdc42 action on actin polymerization.
Cdc42 activation stimulates de novo nucleation of a filament with a
free barbed end by activating a nucleator (Nuc). Elongation at the
barbed end (actin monomers are indicated by triangles) is facilitated by
an elongation-promoting complex (EP) and is protected by an inhibitor
(I) from capping by capping protein (CP). As elongation does not
appear to be limited by capping, we propose that it is terminated by
dissociation of EP. 
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Supplementary materials and methods
Cell extract and capping protein
Cell extract is the high-speed supernatant of rabbit peritoneal exudate
neutrophils, prepared as described previously [S1]. Capping protein
was isolated from chicken brain by the method of Schafer et al. [S2].
Immunodepletion of capping protein
Affinity-purified rabbit polyclonal antibodies directed against the carboxy-
terminal 27 amino acids of the β2-subunit of chicken non-muscle capping
protein were prepared as described [S3]. Depletion was achieved by
incubating HSS with antibody bound to protein A beads or, for mock
depletion, with protein A beads treated with 0.1% BSA or pre-immune
immunoglobulin. The extent of depletion was determined by western blot
analysis using monoclonal antibody 3F2.3, which is specific for the β2-
subunit of capping protein [S3] (from the Hybridoma Bank at the Univer-
sity of Iowa), rabbit anti-mouse IgG and 125I-labeled protein A. Bound
radioactivity was quantified with a phosphorimager (Molecular Dynamics).
Two rabbit polyclonal antibodies (R25 and R26) against capping
protein were used. The extent of depletion by both antibodies was
similar and increased the length of filaments induced by spectrin–actin
seeds but did not increase the length of filaments induced by Cdc42.
Capping protein depletion by R25 partially inhibited Cdc42-induced
polymerization of filamentous actin (F actin). The inhibition was not
restored by addition of pure capping protein. Thus, the inhibition of
polymerization appeared not to be a result merely of capping protein
depletion, a conclusion supported by the fact that comparable deple-
tion by R26 did not inhibit polymerization. 
Cdc42
Recombinant GST–Cdc42 was expressed in a baculovirus insect cell
expression system as described [S4]. The Cdc42 used in these experi-
ments had an ~10-fold lower activity than that used in previous studies
[S1,S3,S4] but appeared equally clean on SDS gels and showed
similar GTPγS binding. Partitioning in Triton X-115 indicated it was less
fully prenylated. The time-course of nucleation and polymerization and
the filament lengths induced by the two Cdc42s were similar given the
10-fold difference in apparent concentration. 
GST–VCA from N-WASP
A construct for GST–VCA, the VCA fragment of N-WASP, a gift of H.
Miki (University of Tokyo), was expressed as a GST fusion protein in
Escherichia coli and purified on glutathione beads. The GST–VCA was
eluted with glutathione and used as GST–VCA.
Arp2/3 complex
Arp2/3 complex was purified from human blood leukocytes. DFP-
treated leukocytes from 6 U freshly drawn human blood were sus-
pended at 4 × 108 cells per ml in 120 mM NaCl, 10 mM KCl, 25 mM
HEPES pH 7.4, 1.2 mM KH2PO4, 1.2 mM MgSO4, brought to 37°C,
and stimulated with 1 µM fMLP for 10 sec. The cells were extracted
with an equal volume of 40 mM Tris-HCl pH 8.0, 2 mM EGTA, 1 mM
MgCl2, 1 mM DTT, 0.5% thesit, 20 µg/ml leupeptin, 10 µg/ml pepstatin
A and centrifuged at 20,000 × g for 5 min. The supernatant was frac-
tionated sequentially over Q Sepharose FF, Source Q15, MonoS and
Superdex200 (Amersham/Pharmacia). Arp2/3 complex was monitored
by immunoblotting using anti-p34 and anti-p40 polyclonal antibodies.
The final preparation was homogeneous, as judged by Coomassie-blue
staining of 5 µg of the purified fraction.
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Supplementary material
Figure S1
The time-course of capping of Arp2/3-nucleated filaments and of
spectrin–actin seeds is similar. (a) Filaments nucleated for 5 min by
VCA (200 nM) and Arp2/3 complex (50 nM) in 2 µM muscle actin
were diluted 100-fold into 1.5 µM pyrenylactin without (open squares,
control) or with 1, 3 or 6 nM capping protein (CP), as indicated, and
the rate of pyrenylactin polymerization was followed over time. Data
shown are individual assays. (b) A concentration of spectrin–actin
seeds resulting in a comparable rate of polymerization in the absence
of capping protein was also diluted into pyrenylactin without (open
squares) or with 1, 3, or 6 nM capping protein, as indicated. The
decrease in the rate of polymerization caused by capping of both
spectrin–actin- and Arp2/3-nucleated filaments was similar.
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